EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Clinical trials for EXTENSIVE-STAGE SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE-STAGE SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for EXTENSIVE-STAGE SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at deadly lung cancer
Disease control Not yet recruitingThis early-phase trial tests a new therapy for people with advanced small cell lung cancer or similar neuroendocrine cancers that have not responded to prior treatment. The approach involves collecting a patient's own immune cells, modifying them in a lab to recognize a protein c…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 05:00 UTC
-
New hope for tough lung cancer: combo therapy enters phase II trial
Disease control Not yet recruitingThis study tests a new drug (BL-M14D1) combined with an approved immunotherapy (atezolizumab) in 36 adults with extensive-stage small cell lung cancer that has no standard treatment. The goal is to see if the combination can shrink tumors and control the disease. Participants mus…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New chemo combo shows promise for tough lung cancer
Disease control Not yet recruitingThis Phase 2 trial tests whether adding lurbinectedin to paclitaxel works better than paclitaxel alone for people with advanced small cell lung cancer that has returned after first treatment. About 69 adults will be randomly assigned to one of two groups. The study measures how m…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug combo aims to outperform standard care in aggressive lung cancer
Disease control Not yet recruitingThis Phase 3 trial will test whether a new drug called BL-M14D1 combined with atezolizumab works better than the current standard treatment for people with extensive-stage small cell lung cancer who have not had prior therapy. About 550 adults will be randomly assigned to receive…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug combo aims to keep lung cancer in check longer
Disease control Not yet recruitingThis Phase 2 trial tests whether combining lurbinectedin (Zepzelca) with durvalumab (Imfinzi) as maintenance therapy can delay cancer growth in people with extensive-stage small-cell lung cancer whose disease has not worsened after initial chemotherapy plus durvalumab. About 50 p…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug duo aims to tackle Hard-to-Treat cancers
Disease control Not yet recruitingThis early-phase study is testing a combination of two experimental drugs, Ris-Rez and ivonescimab, in about 184 adults with advanced solid tumors that have spread. The main goals are to find a safe dose, understand side effects, and see if the combo can shrink tumors. It's a fir…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Promising new combo for tough lung cancer: Low-Dose radiation plus immunotherapy
Disease control Not yet recruitingThis study tests a new treatment for people with extensive-stage small cell lung cancer, a fast-growing cancer that has spread. It combines low-dose radiation to the chest with an immunotherapy drug (adebrelimab) and chemotherapy, followed by maintenance immunotherapy for up to t…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Jiangmen Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New triple combo targets tough lung cancer liver spread
Disease control Not yet recruitingThis study tests whether adding radiation to immunotherapy and chemotherapy can help people with advanced small-cell lung cancer that has spread to the liver. It includes 30 adults aged 18-75 whose cancer did not respond to or stopped responding to prior treatments. The goal is t…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for aggressive lung cancer: drug duo takes on chemo in major trial
Disease control Not yet recruitingThis study tests a new combination of drugs (BL-B01D1 and tislelizumab) against standard chemotherapy plus tislelizumab as the first treatment for people with extensive-stage small cell lung cancer, a fast-growing cancer. About 562 adults with good performance status will join th…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New hope for tough lung cancer: drug combo targets tumors after first treatment fails
Disease control Not yet recruitingThis study tests a combination of two drugs, sacituzumab tirumotecan and anlotinib, in 30 people with extensive-stage small cell lung cancer whose disease got worse after initial chemotherapy plus immunotherapy. The goal is to see if the combo can shrink tumors or slow cancer gro…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: China Medical University, China • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Researchers observe how lung cancer patients fare in real life
Knowledge-focused Not yet recruitingThis study will follow 96 adults with extensive-stage small cell lung cancer to see how they are treated in everyday hospital settings and how they respond. Doctors will choose treatments as usual, and researchers will collect data from medical records and regular check-ins every…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:07 UTC